Public Comments to Agencies
Comments to FDA on Modified Risk Tobacco Product Applications
March 21, 2018 Commissioner Scott Gottlieb, M.D. Food and Drug Administration Dockets Management Staff HFA-305 5630 Fishers Lane Room 1061 Rockville, Maryland 20852 Attention
Comments on FCC 2018 Lifeline Reform Proposal
[PDF DOWNLOAD] BEFORE THE FEDERAL COMMUNICATIONS COMMISSION
Comments to FDA Tobacco Products Scientific Advisory Committee
December 11, 2017 Caryn Cohen, M.S. Office of Science Center for Tobacco Products Food and Drug Administration Document Control Center Building 71, Room G335 10903 New Hampshire Avenue Silver Spring, MD 20993-0002
CAGW Comments on Federal Motor Vehicle Safety Standards: V2V Communications
September 7, 2017 The Honorable Elaine Chao Secretary U.S. Department of Transportation 1200 New Jersey Avenue, S.E. Washington, D.C. 20590 Ref: Federal Motor Vehicle Safety Standards: V2V Communications Docket No. NHTSA-2016-0126
Centers for Medicare and Medicaid Comments on Biosimilars
August 28, 2017 Centers for Medicare and Medicaid Department of Health and Human Services P.O. Box 8016 Baltimore, Maryland 21244-8013
FDA Comments Supporting Tobacco Harm Reduction Products
August 10, 2017 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
Supporting the Petitions for Reconsideration of the FCC's Privacy Order
BEFORE THE FEDERAL COMMUNICATIONS COMMISSION Washington, D.C. In the Matter of ) )
